medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2020, Number 1

<< Back Next >>

Cir Card Mex 2020; 5 (1)

Total artificial heart: case report and operative technique
Qui fecerit machina fit idea de arti

Orozco-Hernández EJ, Tallaj J, Davies JE, Gongora E, Kirklin JK, Hoopes CW

Language: English
References: 6
Page: 9-17
PDF size: 1148.87 Kb.


ABSTRACT

The Syncardia total artificial heart (TAH-t) is a pneumatically driven partially implantable system , offers 2 sizes, 70 mL and 50 mL, capable of generating cardiac outputs of up to 9.5 L/m and 7.5 L/min, respectively. This system is used for orthotopic replacement of the native ventricles in patients with irreversible biventricular heart failure. . It is an excellent option in the properly selected patient. The keys to successful device implantation remain patient selection, operative techniques aimed to facilitate orthotropic heart transplantation, centers of high volume and profound knowledge of postoperative management. We present a case that was successfully bridge to OHT with a TAH-t. We will review specific strategies, surgical technique, important operative details, teaching points and pitfalls of the TAH implantation, allowing a less demanding reoperation for orthotopic heart transplantation.


REFERENCES

  1. Slepian MJ, Copeland JG. The total artificial heart in refractory cardiogenicshock: saving the patient versus saving the heart. Nat Clin Pract Cardiovasc Med 2008;5:64–5.

  2. Slepian MJ, Smith RG, Covington D, et al. Translatable performance with the totalartificial heart: the US postmarket study. J Heart Lung Transplant 2012;31:S 88-9.

  3. Copeland JG. SynCardia Total Artificial Heart: update and future. Tex Heart Inst J2013;40:587-8.

  4. Arabia FA, Cantor RS, Koehl DA, et al. INTERMACS report on the total artificialheart. J Heart Lung Transplant 2018; 37:1304-12.

  5. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patientswith the HeartMate II continuous-flowleft ventricular assist device: incidence, riskfactors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316-24.

  6. Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report:15,000 patients and counting. J Heart Lung Transplant 2015;34:1495-1504.




2020     |     www.medigraphic.com